Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Show Therapeutic Classes
Legacy Hazardous Drugs Do Not Tube List
QR Code Add Formweb to your mobile device
Android iOS
Approved Hospital Formulary
Pharmacy - Home (sharepoint.com) Contact Pharmacy
Search results for:

palivizumab

palivizumab
Brand names: Synagis
Form Strength
SOLUTION, INTRAMUSCULAR 100 mg/mL
VIEW MORE Monoclonal Antibodies
CLASS
081824
Additional Information:
Drug Name Common Side Effects

palivizumab
  • fever
  • rash
  • hypersensitivity reaction
 
Non-Formulary - Palivizumab is no longer recommended by American Academy of Pediatric and will not be manufactured moving forward.  See FormWeb • nirsevimab.
Last updated: Oct. 17, 2025






This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved